Inhibition and induction of human cytochrome P450 (CYP) enzymes.
Pelkonen
O
O
Department of Pharmacology and Toxicology, University of Oulu, Finland.
Mäenpää
J
J
Taavitsainen
P
P
Rautio
A
A
Raunio
H
H
D000983:Antipyrine / Q000378:metabolism / Q000494:pharmacology; D015283:Citalopram / Q000378:metabolism / Q000494:pharmacology; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004789:Enzyme Activation / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D008658:Inactivation, Metabolic; D008099:Liver / Q000201:enzymology; D008874:Midazolam / Q000494:pharmacology; D012907:Smoking; D013379:Substrate Specificity
D065607:Cytochrome P-450 Enzyme Inhibitors; D004791:Enzyme Inhibitors; D015283:Citalopram; D003577:Cytochrome P-450 Enzyme System; D008874:Midazolam; D000983:Antipyrine